Microbial Identification MarketMicrobial identification or identification of microorganisms such as harmful bacteria and fungi plays a central role in the quality control (QC) microbiology lab. Identification measures of microbes include – microscopy and specimen biochemical test. The ability to identify exactly which microorganism strain is present in a sample is a fundamental need of almost all microbiologists. These rapid molecular techniques are now replacing traditional culture-based methods.

According to a research report published in Markets and Markets, this microbial identification market is estimated at $896.5 million in 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019. The research report is titled “Microbial Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages) & by End User (Detection, Characterization) – Global Forecasts to 2019”.

Factors that contribute to the growth of this market are:

  • Technological advancements
  • High prevalence of infectious diseases
  • Growing food safety concerns
  • Government initiatives
  • Higher healthcare expenditure in the emerging geographies

End users for microbial characterization are government/private institutes, hospitals, and diagnostic laboratories, pharmaceutical and biotechnology companies, and CROs and independent research laboratories.

The prominent players in the microbial identification market include РBecton, Dickinson and Company, (U.S.), bioMérieux SA (France), Bruker Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Siemens healthcare (Germany).

Geographically, North America dominates the market, followed by Europe, Asia-pacific and the Rest of the World (ROW).